Back to search results

Biofield Therapy (Reiki) for Immunotherapy Side Effects

This pilot study is exploring whether a complementary therapy called Usui Reiki can help adults with cancer who are receiving immunotherapy and experiencing fatigue, pain, and stress. Reiki is a gentle, non-invasive technique where a trained practitioner places their hands lightly near your body to promote relaxation and well-being. You may be able to join if you are over 18, have cancer, are currently on immunotherapy (like PD1 or PD-L1 inhibitors), and have significant fatigue. The study will measure changes in your fatigue and pain levels before and after each Reiki session to see if this intervention is helpful. The study plans to enroll 12 participants.

Study design
This is an interventional pilot study planning to enroll 12 participants. It is not specified if it is randomized or blinded.
What's involved
You would receive six weekly, in-person Usui Reiki sessions, each lasting about 30 minutes. Your fatigue and pain levels will be measured before and after each session.
Compensation
Not stated in the trial record.
Follow-up
Your fatigue and pain will be measured before and after each of the 6 weekly Reiki sessions, from Baseline (Week 1) to Week 6.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07581080

Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study

Recruiting
NAAges 18+InterventionalSupportive care
University of California, Irvine
~12 participants
Updated 2026-07-10 on ClinicalTrials.gov
What's tested:Usui Reiki Intervention

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Fatigue (Multidimensional Fatigue Symptom Inventory-Short Form Total Score)
Measured over Before and after each of the 6 weekly Reiki sessions
+1 more outcome measured

Conditions

Cancer
Immunotherapy
Fatigue Related to Cancer Treatment
Pain
Stress

Explore related trials

Malignant Neoplasm

Where it's being run

2 sites across 1 states
California2

Who to contact

Dalia Kagramanov, PhD
[email protected]
323-961-2728
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participants must be greater than 18 years of age.
Currently diagnosed with cancer.
Actively receiving immunotherapy treatment with ICI (PD1 or -PD-L1 inhibitor (single-agent immunotherapy or immunotherapy in combination with other agents; also including the use of steroids if applicable)
Report clinically significant fatigue over the past 7 days.
Able to travel to the study site to receive Reiki treatments once a week.
Understanding and willing to complete all study procedures.
Capable of giving written informed consent.
Proficient ability to speak, read, and write in English or Spanish.

Exclusion

Individuals currently receiving or received Reiki treatment in the past 30 days
Currently diagnosed with a severe psychiatric illness (i.e. schizophrenia, dementia, major depression with suicidal ideations)
Currently pregnant or intending to become pregnant during the study timeframe

What this trial measures

  • Change in Fatigue (Multidimensional Fatigue Symptom Inventory-Short Form Total Score)Before and after each of the 6 weekly Reiki sessions

    Fatigue will be assessed using the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF), a validated self-report questionnaire measuring general, physical, emotional, and mental fatigue, as well as vigor. Scores will be used to evaluate changes in fatigue severity over time. Total scores range from -24 to 96, with higher scores indicating greater fatigue (worse outcome).

  • Change in PainBaseline (Week 1) to Week 6 of the intervention arm (before and after each Reiki session)

    Pain will be assessed using a Visual Analog Scale (VAS) ranging from 0 to 10, where 0 indicates no pain and 10 indicates worst possible pain (higher scores = worse outcome)